News & Reports

 

News, research reports and other items of interest to the policymaking community, from the Center for Evidence-based Policy and our partners.

Sofosbuvir for the Treatment of Hepatitis C

With the FDA approval of sofosbuvir, clinicians and purchasers will need to decide whether to include sofosbuvir in their treatment protocols for HCV infection. This report evaluates the evidence about the effectiveness and harms of sofosbuvir treatment for HCV, evaluates the AASLD guideline, and provides a compilation of the evidence to guide decisions on who and when to treat.

View Report

 

Health Technology Assessment—Rapid Assessment

This report describes well-developed HTA programs from the US, Canada, Australia and select European countries. Individual HTA programs were identified on the availability of having documents in English and/or that were discussed in the International Journal of Technology Assessment in Health Care 2009 supplemental volumes (Suppl 1 and 2) on HTA programs.

Read More